Common cardiovascular biomarkers can independently predict outcome of patients with Myelodysplastic syndromes

Blood Cancer J. 2023 May 3;13(1):64. doi: 10.1038/s41408-023-00844-4.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Humans
  • Myelodysplastic Syndromes* / diagnosis
  • Prognosis

Substances

  • Biomarkers